{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T14:01:00Z","timestamp":1780581660243,"version":"3.54.1"},"reference-count":37,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,9,20]],"date-time":"2021-09-20T00:00:00Z","timestamp":1632096000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p><jats:bold>Introduction:<\/jats:bold> Liver fibrosis staging is of great importance for reducing unnecessary injuries and prompting treatment in chronic viral hepatitis B patients. Liver biopsy is not suitable to act a screening method although it is a gold standard because of various shortcomings. This study aimed to establish a predictive nomogram as a convenient tool to effectively identify potential patients with different stages of liver fibrosis for patients with chronic hepatitis B.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> A nomogram for multinomial model was developed in a training set to calculate the probability for each stage of fibrosis and tested in a validation set. Fibrosis stages were subgrouped as followed: severe fibrosis\/cirrhosis (F3\u2013F4), moderate fibrosis (F2), and nil-mild fibrosis (F0\u2013F1). The indicators were demographic characteristics and biochemical indicators of patients. Continuous indicators were divided into several groups according to the optimal candidate value generated by the decision tree.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> This study recruited 964 HBV patients undergoing percutaneous liver biopsy. The multinomial model with 10 indicators was transformed into the final nomogram. The calibration plot showed a good agreement between nomogram-predicted and observed probability of different fibrosis stages. Areas under the receiver operating characteristics (AUROCs) for severe fibrosis\/cirrhosis were 0.809 for training set and 0.879 for validation set. For moderate fibrosis, the AUROCs were 0.75 and 0.781. For nil-mild fibrosis, the AUROCs were 0.792 and 0.843. All the results above showed great predictive performance in predicting the stage of fibrosis by our nomogram.<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> Our model demonstrated good discrimination and extensibility in internal and external validation. The proposed nomogram in this study resulted in great reliability and it can be widely used as a convenient and efficient way.<\/jats:p>","DOI":"10.3389\/fmed.2021.669800","type":"journal-article","created":{"date-parts":[[2021,9,20]],"date-time":"2021-09-20T06:30:10Z","timestamp":1632119410000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["A Generic Nomogram Predicting the Stage of Liver Fibrosis Based on Serum Biochemical Indicators Among Chronic Hepatitis B Patients"],"prefix":"10.3389","volume":"8","author":[{"given":"Xueying","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wusheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qimeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weijie","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingcheng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiantian","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongbo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,9,20]]},"reference":[{"key":"B1","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-319-22330-8_9","volume-title":"Global Epidemiology of Hepatitis B Virus Infection","author":"Lavanchy","year":"2016"},{"key":"B2","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1111\/j.1365-2893.2009.01088.x","article-title":"Noninvasive diagnosis of liver fibrosis in patients with HIV infection and HCV\/HBV co-infection","volume":"16","author":"Moreno","year":"2009","journal-title":"J Viral Hepat."},{"key":"B3","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1111\/j.1365-2893.2004.00519.x","article-title":"Treatment of patients with HCV infection with or without liver biopsy","volume":"11","author":"Andriulli","year":"2004","journal-title":"J Viral Hepat."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jhep.2008.10.014","article-title":"Liver biopsy: the best, not the gold standard","volume":"50","author":"Bedossa","year":"2009","journal-title":"J Hepatol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"519","DOI":"10.3949\/ccjm.77a.09138","article-title":"Noninvasive tests for liver disease, fibrosis, and cirrhosis: Is liver biopsy obsolete?","volume":"77","author":"Carey","year":"2010","journal-title":"Cleve Clin J Med."},{"key":"B6","first-page":"1583","article-title":"High sensitive CRP and pentraxine 3 as noninvasive biomarkers of nonalcoholic fatty liver disease","volume":"18","author":"Maleki","year":"2014","journal-title":"Eur Rev Med Pharmacol Sci."},{"key":"B7","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1111\/hepr.12385","article-title":"Value of Egy-Score in diagnosis of significant, advanced hepatic fibrosis and cirrhosis compared to aspartate aminotransferase-to-platelet ratio index, FIB-4 and Forns' index in chronic hepatitis C virus","volume":"45","author":"Alboraie","year":"2015","journal-title":"Hepatol Res."},{"key":"B8","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.transproceed.2008.12.014","article-title":"APRI and FIB-4 scores are useful after liver transplantation independently of etiology","volume":"41","author":"Pissaia","year":"2009","journal-title":"Transplant Proc."},{"key":"B9","doi-asserted-by":"publisher","first-page":"9798","DOI":"10.1158\/0008-5472.can-10-1001","article-title":"Serum microRNA profiles serve as novel biomarkers for HBV infection and diagnosis of HBV-positive hepatocarcinoma","volume":"70","author":"Li","year":"2010","journal-title":"Cancer Res."},{"key":"B10","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.jclinepi.2015.10.016","article-title":"A nomogram was developed to enhance the use of multinomial logistic regression modeling in diagnostic research","volume":"71","author":"Bertens","year":"2016","journal-title":"J Clin Epidemiol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/1471-230X-5-32","article-title":"Serum hyaluronate as a non-invasive marker of hepatic fibrosis and inflammation in HBeAg-negative chronic hepatitis B","volume":"5","author":"Montazeri","year":"2005","journal-title":"BMC Gastroenterol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"313","DOI":"10.5009\/gnl.2014.8.3.313","article-title":"Gallstone disease does not predict liver histology in nonalcoholic fatty liver disease","volume":"8","author":"Yilmaz","year":"2014","journal-title":"Gut Liver."},{"key":"B13","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1186\/s12876-014-0218-6","article-title":"HBV DNA level could predict significant liver fibrosis in HBeAg negative chronic hepatitis B patients with biopsy indication","volume":"14","author":"Praneenararat","year":"2014","journal-title":"BMC Gastroenterol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12072-015-9675-4","article-title":"Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update","volume":"10","author":"Sarin","year":"2016","journal-title":"Hepatol Int."},{"key":"B15","doi-asserted-by":"publisher","first-page":"3163","DOI":"10.1200\/JCO.2010.33.1595","article-title":"Nomograms for predicting local recurrence, distant metastases, and overall survival for patients with locally advanced rectal cancer on the basis of European randomized clinical trials","volume":"29","author":"Valentini","year":"2011","journal-title":"J Clin Oncol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1186\/s12885-016-2684-4","article-title":"Nomograms to predict survival after colorectal cancer resection without preoperative therapy","volume":"16","author":"Zhang","year":"2016","journal-title":"BMC Cancer."},{"key":"B17","first-page":"849","article-title":"A streaming parallel decision tree algorithm","volume":"11","author":"Ben Haim","year":"2010","journal-title":"J Mach Learn Res."},{"key":"B18","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1177\/0962280214560045","article-title":"Widen NomoGram for multinomial logistic regression: an application to staging liver fibrosis in chronic hepatitis C patients","volume":"26","author":"Ardoino","year":"2017","journal-title":"Stat Methods Med Res."},{"key":"B19","doi-asserted-by":"publisher","first-page":"11524","DOI":"10.1038\/s41598-017-11227-8","article-title":"Development and validation of a nomogram for predicting survival in patients with advanced pancreatic ductal adenocarcinoma","volume":"7","author":"Deng","year":"2017","journal-title":"Sci Rep."},{"key":"B20","doi-asserted-by":"publisher","first-page":"e020609","DOI":"10.1136\/bmjopen-2017-020609","article-title":"Establishment of blood pressure nomograms representative for Egyptian children and adolescents: a cross-sectional study","volume":"8","author":"El-Shafie","year":"2018","journal-title":"BMJ Open."},{"key":"B21","doi-asserted-by":"publisher","first-page":"7005","DOI":"10.1200\/JCO.2005.01.867","article-title":"Postoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy","volume":"23","author":"Stephenson","year":"2005","journal-title":"J Clin Oncol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1002\/hep.510240201","article-title":"An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group","volume":"24","author":"Bedossa","year":"1996","journal-title":"Hepatology."},{"key":"B23","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1002\/hep.24013","article-title":"Noninvasive assessment of liver fibrosis","volume":"53","author":"Martinez","year":"2011","journal-title":"Hepatology."},{"key":"B24","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1097\/MEG.0b013e32830dfcb3","article-title":"King's Score: an accurate marker of cirrhosis in chronic hepatitis C","volume":"21","author":"Cross","year":"2009","journal-title":"Eur J Gastroenterol Hepatol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1002\/hep.21335","article-title":"Modeling hepatic fibrosis in African American and Caucasian American patients with chronic hepatitis C virus infection","volume":"44","author":"Fontana","year":"2006","journal-title":"Hepatology."},{"key":"B26","doi-asserted-by":"publisher","first-page":"158139","DOI":"10.3390\/ijms22158139","article-title":"Diagnosis and therapeutic management of liver fibrosis by MicroRNA","volume":"22","author":"Tadokoro","year":"2021","journal-title":"Int J Mol Sci."},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1109\/JBHI.2021.3100319","article-title":"Multiparametric quantitative US examination of liver fibrosis: a feature-engineering and machine-learning based analysis","author":"Wen","year":"2021","journal-title":"IEEE J Biomed Health Inform"},{"key":"B28","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/978-1-4419-5913-3","article-title":"A robust ensemble classification method analysis","volume":"680","author":"Zhang","year":"2010","journal-title":"Adv Exp Med Biol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1053\/jhep.2002.36128","article-title":"Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model","volume":"36","author":"Forns","year":"2002","journal-title":"Hepatology."},{"key":"B30","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1111\/j.1572-0241.2005.41289.x","article-title":"Identification of chronic hepatitis B patients without significant liver fibrosis by a simple noninvasive predictive model","volume":"100","author":"Hui","year":"2005","journal-title":"Am J Gastroenterol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"501","DOI":"10.3748\/wjg.v16.i4.501","article-title":"Staging of liver fibrosis in chronic hepatitis B patients with a composite predictive model: a comparative study","volume":"16","author":"Wu","year":"2010","journal-title":"World J Gastroenterol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1111\/jvh.13031","article-title":"Evaluation and comparison of thirty noninvasive models for diagnosing liver fibrosis in chinese hepatitis B patients","volume":"26","author":"Dong","year":"2019","journal-title":"J Viral Hepat."},{"key":"B33","volume-title":"Guidelines for the Prevention, Care and Treatment of Persons with Chronic Hepatitis B Infection","year":"2015"},{"key":"B34","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.ejim.2015.07.005","article-title":"Online combination algorithm for non-invasive assessment of chronic hepatitis B related liver fibrosis and cirrhosis in resource-limited settings","volume":"26","author":"Salkic","year":"2015","journal-title":"Eur J Intern Med."},{"key":"B35","doi-asserted-by":"publisher","first-page":"5218930","DOI":"10.1155\/2020\/5218930","article-title":"A novel diagnostic nomogram for noninvasive evaluating liver fibrosis in patients with chronic hepatitis B virus infection","volume":"2020","author":"Cheng","year":"2020","journal-title":"Biomed Res Int."},{"key":"B36","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1186\/s12876-021-01774-w","article-title":"Nomogram for predicting advanced liver fibrosis and cirrhosis in patients with chronic liver disease","volume":"21","author":"Ding","year":"2021","journal-title":"BMC Gastroenterol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"335","DOI":"10.5009\/gnl.2013.7.3.335","article-title":"miR-197 expression in peripheral blood mononuclear cells from hepatitis B virus-infected patients","volume":"7","author":"Chen","year":"2013","journal-title":"Gut Liver."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2021.669800\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,20]],"date-time":"2021-09-20T06:30:16Z","timestamp":1632119416000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2021.669800\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,20]]},"references-count":37,"alternative-id":["10.3389\/fmed.2021.669800"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2021.669800","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,20]]},"article-number":"669800"}}